Blueberry Therapeutics Ltd

Abliance masters essential technologies to develop new generation antibodies. Our team of experts closely works with research laboratories, diagnostic industry, actors of clinical research and biopharmaceutical industry to understand the needs associated with each application, its regulatory environment and economic constraints. Abliance provides antibodies that perform in their application by designing unique solutions.

Caltag Medsystems (CML) has Four Business Divisions:

1. Distribution of Bioscience and Biomedical reagents and kits to the European markets. Key customer groups are Universities, Hospitals, Pharmaceutical Companies, Biotechnology Companies, Private Laboratories. Caltag Medsystems represents over 50 overseas manufacturers from all quarters of the globe. We are looking for new suppliers who fit with our product portfolio and business strategy.
The Cell Culture section of our portfolio includes human and animal primary cells, stem cells, cell lines and media, skin, healthy & diseased human biological materials, angiogenesis models and transfection reagents. Sample types include blood, plasma, serum, bone marrow, CSF, urine, synovial fluid and many more, and are available as matched samples where needed. We supply reagents for the detection of a wide range of different disease biomarkers, together with primary cells and tissue from 26 different cell systems in the human body. Our human biological materials range is extensive, encompassing a wide range of sample types from normal and diseased individuals.
ELISA Kits, Antibodies, Biochemicals and Small Molecules. We provide over 18,000 ELISA kits across a wide range of disease biomarkers including those for apoptosis, cardiovascular, infection and immunity, cytokine and metabolism research and many more. Antibodies, proteins and controls are also available individually.

2. Cytomark Division (www.cytomark.co.uk) - manufacturer of TransFix for stabilisation of whole blood, cerebrospinal fluid, bone marrow and biopsy samples.

3. Cellworks Division (www.cellworks.co.uk) - manufacturer of primary cell models, primary cells, medium and other primary cell reagents. The Cellworks Division is looking for distributors in countries not already represented on our website.

4. Laboratory Services - CRO laboratory services such as Cell Expansion, Flow Cytometry and Angiogenesis service.

Within Basel neighbourhood and at the very heart of Europe (the triple border of France, Germany and Switzerland), Firalis is a pioneering biotechnology company, active in discovery, development and qualification of biomarkers (BM).

1) BIOMARKER PRODUCTS
Firalis develops BM-based diagnostic, prognostic and theranostic tools:
● RUO Kits (Research-Use-Only), based on validated innovative biomarkers
● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified biomarkers

2) BIOMARKER R&D
● Development of proprietary BMs
- Cardiovascular, Inflammatory, Autoimmune and Neurology
● Drug Safety & Drug Efficacy
● Patient Stratification
● Personalized Medicine

3) BIOMARKER-RELATED CRO SERVICES
BM Discovery for laboratories, biotechs and pharmaceutical industry:
- Proteomics: Soluble biomarker measurements with several immunoassays technologies (ELISA, multiplex and high sensitivity platforms such as Luminex® BioPlex 200™, Meso Scale Discovery®, Singulex Erenna®, Protein Simple Ella™, Olink and Siemens Dimension® EXL™ 200)
- Genomics/Transcriptomics: Targeted sequencing of miRNA and mRNA (HTG EdgeSeq), lncRNA screening via Firalis proprietary platform, Next-Generation Sequencing (NGS) services (RNA-Seq, whole genome and exome sequencing, etc.) and qPCR/microfluidic qPCR (Gene Expression, SNP, CNV, etc.)
- Flow Cytometry: Immunophenotyping of preclinical and clinical samples, monitoring of pharmacodynamics on target cells in response to treatment and biomarker discovery
- Assay development and validation on various platforms, development of critical reagents (antibodies and proteins)
- Biobanking and sample repository services supported by LIMS
- Data analysis using multi-parametric statistics and development of predictive models
- Support of regulatory activities related to biomarker qualification with Health Authorities (FDA/EMA)
- Quality environment (ISO 9001, ISO 13485 (GMP), ISO 17025 (GLP/GCLP))

For more information please visit our website.

Pepceuticals Limited, established in 1998, is a specialist British manufacturer of synthetic peptides. We remain dedicated to supplying the Life Science industry with high-quality custom peptides and an antibody manufacturing service. Over the years, Pepceuticals has established a reputation for excellence in the field of peptide synthesis, having developed novel technologies that allow us to prepare complex peptide molecules. We are committed to providing solutions to researchers globally by continuing to increase our development program of large and small synthetic peptide libraries, and enhancing the prospects of obtaining new research candidates.

We provide a comprehensive drug development program that allows us to furnish peptides manufactured under cGMP, from milligram to kilogram quantities and to support all aspects of peptide manufacture. Furthermore, we also have an active program to develop generic peptide active substances (API’s) that cover many different disease areas.

At Pepceuticals, we operate a stringent Pharmaceutical Quality System which verifies that the products we supply meet or exceed industry standards. Pepceuticals holds an API manufacturing licence as granted by the MHRA (Medicines and Healthcare Products Regulatory Agency) and BSI ISO 2001-2015 accreditation from the British Standards Industry (BSI) for our manufacturing practices. Our Quality Control (QC) team, ensure that our instrumentation, operating/ testing, and staff training are maintained and continually updated to achieve these high standards. Our aim is to deliver all our products in a reliable time frame with a full certificate of analysis and supporting data.

We ensure effective project management and good communication with all our clients; from sales to product delivery we aspire to offer a complete solution. We trust that you will enjoy the benefits of working with Pepceuticals, as a reliable, flexible and innovative peptide manufacturer.

Your Partner for Toxicity and Immunotoxicity Studies

vivo Science is a Contract Research Organization located in Germany performing standard rodent toxicology and is specialized in immunogenetic and immunotoxicology studies. All studies are either Good Manufacturing Practice (GMP) or Good Laboratory Practice (GLP) compliant depending upon the specific requirement.

Our experience is with the biopharmaceutical industry and large molecules as well as with small molecules. The study and report design are appropriate for submission to the pharmaceutical regulatory agencies. We also have experience in studies as described in the new European REACH guidelines for submission to the appropriate authorities.